Literature DB >> 22726797

Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy.

Sunday O Akintoye1, Elliot V Hersh.   

Abstract

Entities:  

Year:  2012        PMID： 22726797     DOI： 10.1016/j.jebdp.2012.03.003

Source DB:  PubMed          Journal:  J Evid Based Dent Pract        ISSN： 1532-3382            Impact factor:   5.267


× No keyword cloud information.
  2 in total

1.  Osteonecrosis of the jaw from bone anti-resorptives: impact of skeletal site-dependent mesenchymal stem cells.

Authors:  So Akintoye
Journal:  Oral Dis       Date:  2013-10-07       Impact factor: 3.511

2.  Impact of communication between physicians and dentists on the incidence of jaw osteonecrosis caused by bone anti-resorptives.

Authors:  Sunday O Akintoye; Elliot V Hersh
Journal:  Curr Med Res Opin       Date:  2016-05-18       Impact factor: 2.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.